Drug & intervention

foscarnet

RxCUI 33562

Clinical trials2

Recruiting0

Related conditions3

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Background context

Foscarnet

Foscarnet (phosphonomethanoic acid), known by its brand name Foscavir, is an antiviral medication which is primarily used to treat viral infections involving the Herpesviridae family. It is classified as a pyrophosphate analog DNA polymerase inhibitor. Foscarnet is the conjugate base of a chemical compound with the formula HO2CPO3H2 (Trisodium phosphonoformate). Foscarnet was approved for medical use in 1991. It is available as a generic medication.

Read on Wikipedia ↗ Wikidata Q420387 ↗

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

2 shown

Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)NCT00000134 · 1992-12-01

COMPLETED

Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)NCT00000136 · 1990-03-01

COMPLETED

Conditions being studied

Cytomegalovirus Retinitis2 HIV Infections2 Acquired Immunodeficiency Syndrome1

Leading sponsors

Johns Hopkins Bloomberg School of Public Health2

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.